-
Sort By
-
Newest
-
Newest
-
Oldest
-
All Categories
-
All Categories
-
Alternatives
-
ASX
-
Crypto
-
ESG
-
ETFs
-
Global
-
Growth
-
IPO
-
M&A
-
Small caps
-
Unlisted Assets
-
Value
To tackle the mental illness and social isolation that can tragically accompany ageing, six AI characters have been recruited to offer patience, empathy, knowledge and friendly encouragement to those suffering.
The Australian Energy Market Commission insists consumers are protected in its final ruling. The National Seniors Association begs to differ, arguing these changes will punish those who don’t understand how to change their energy use.
With Australia in the early stages of a $3.5 trillion wealth transfer, there are significant opportunities for charities to benefit. Luckily for them, a growing number of families agree that their wealth should be more equitably shared.
The biotech giant is poised for a strong performance, building on a solid set of numbers posted in 2024. The wildcard remains a Donald Trump presidency and the potential for disruptive economic policies.
Australia’s largest private healthcare provider is growing turnover, making a profit and rewarding shareholders. It’s still failing to impress a sharemarket that is constantly being reminded of the sector’s poor health.
The Big Australian will have to navigate the inevitable tensions between Beijing and the White House over the next four years. A strong cash flow and rising demand for some its key commodities such as copper and potash will make its task easier.
The first quarter of 2024-25 saw the largest supermarket player grow its sales. This positive result was more than offset by a combination of regulatory and political factors, higher operating costs and growing competition from Amazon.
Investment in technology, strengthening infrastructure, expanding product offerings and acquisitions are underpinning this financial services company’s strong earnings performance – and investors are lapping it up.
It’s an enviable record no other listed company can match. For more than 120 years, through major conflicts and economic upheaval, this diversified investment house has always kept shareholders top of mind, not missing a beat on the dividend front since listing in 1903.
While less and less people use cash, for many seniors, uncomfortable using debit or credit cards, banking online or simply fearful of potential scams, it remains the payment system of choice.
With no cure in sight, and the WHO predicting increasing cases of dementia as the population ages, it is critical society becomes more adept at dealing with this illness, especially with research showing many of those afflicted can respond positively to myriad activities and the right living environment.
Higher interest payments and inflation are taking their toll on the banks, with ANZ no different to two of its peers with a lower profit number. That didn’t stop Australia’s fourth biggest mortgage lender increasing the 2024 dividend to shareholders.